Edition:
India

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

599.85INR
22 Jun 2018
Change (% chg)

Rs-2.20 (-0.37%)
Prev Close
Rs602.05
Open
Rs600.95
Day's High
Rs605.60
Day's Low
Rs594.50
Volume
1,711,170
Avg. Vol
948,618
52-wk High
Rs746.00
52-wk Low
Rs493.50

Chart for

About

Glenmark Pharmaceuticals Limited is a global pharmaceutical company. The Company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW). It has approximately seven molecules, over two NCEs and... (more)

Overall

Beta: 0.27
Market Cap(Mil.): Rs172,813.91
Shares Outstanding(Mil.): 282.17
Dividend: 2.00
Yield (%): 0.33

Financials

  GLEN.NS Industry Sector
P/E (TTM): 14.21 30.95 32.74
EPS (TTM): 43.09 -- --
ROI: -- 14.84 14.38
ROE: -- 16.34 16.08

BUZZ-India's Glenmark Pharmaceuticals drops most in over 3 months

** Shares of Glenmark Pharmaceuticals Ltd fall nearly 5 pct to 505.5 rupees, their lowest since May 22

30 May 2018

BRIEF-Glenmark Pharma Says Co Suspended Trial Conducted at Malpani Hospital After Alleged Irregularities

* CLARIFIES ON NEWS ITEM ABOUT CO GETTING NOTICE OVER MISCONDUCT IN CLINICAL TRIALS

04 May 2018

MEDIA-India's Glenmark Pharma gets notice over misconduct in clinical trials - Mint

- Note: Reuters has not verified this story and does not vouch for its accuracy

04 May 2018

BRIEF-Glenmark Pharmaceuticals Gets ANDA Approval For Clobetasol Propionate Topical Solution USP

* GETS ANDA APPROVAL FOR CLOBETASOL PROPIONATE TOPICAL SOLUTION USP

20 Apr 2018

BRIEF-Glenmark Pharmaceuticals Gets ANDA Approval For Tacrolimus Ointment, 0.1 Pct

* SAYS CO GETS ANDA APPROVAL FOR TACROLIMUS OINTMENT, 0.1 PERCENT Source text - http://bit.ly/2HKxf5K Further company coverage:

18 Apr 2018

BRIEF-Glenmark Pharmaceuticals, Helsinn Group Enter Into Agreement For Launch Of Akynzeo In India And Nepal

* SAYS CO, HELSINN GROUP ENTER INTO EXCLUSIVE LICENSING AGREEMENT FOR LAUNCH OF AKYNZEO IN INDIA AND NEPAL

04 Apr 2018

BRIEF-Glenmark Pharmaceuticals Gets ANDA Approval From U.S. FDA For Clobetasol Propionate Spray, 0.05 Pct

* SAYS ‍CO GETS ANDA APPROVAL FROM U.S. FDA FOR CLOBETASOL PROPIONATE SPRAY, 0.05 PERCENT

27 Mar 2018

BRIEF-Glenmark Pharma Enters Exclusive Collaboration Agreement with SCD Pharmaceuticals

* GLENMARK PHARMACEUTICALS - ‍ENTERED INTO EXCLUSIVE DEAL WITH SAM CHUN DANG PHARM

21 Feb 2018

BUZZ-India's Glenmark Pharmaceuticals hits 44-mth low on disappointing Q3 results

** Shares of Glenmark Pharmaceuticals Ltd drop as much as 9.6 pct to 524 rupees, lowest since May 28, 2014

09 Feb 2018

BRIEF-India's Glenmark Pharmaceuticals Dec-Qtr Consol Profit Falls 78 Pct

* DEC QUARTER CONSOL PROFIT 1.05 BILLION RUPEES VERSUS PROFIT OF 4.77 BILLION RUPEES LAST YEAR

08 Feb 2018

Earnings vs. Estimates